Literature DB >> 9869335

Effects of Estradiol (-17beta) on learning, memory and cerebral energy metabolism in male rats after intracerebroventricular administration of streptozotocin.

H Lannert1, P Wirtz, V Schuhmann, R Galmbacher.   

Abstract

Treatment of adult rats with intracerebroventricularly (i.c.v.) injected streptozotocin (STZ) may provide a relevant animal model of chronic neuronal dysfunction that is characterized by a decrease in both the neuronal metabolism of glucose and the formation of energy. The present study was designed to evaluate whether or not rats treated with triplicate i.c.v. STZ injection would show long-term effects in learning and memory behavior as measured by means of a holeboard test, closed field activity, and passive avoidance behavior over a period of 6 weeks. For this purpose, animals with good performance were discriminated from those with poor performance by the holeboard test before i.c.v. administration of STZ. After a 1-week training period with the holeboard all animals improved their abilities in learning and memory, and the improvement was maintained over the investigation period of 6 weeks in the control group. After i.c.v. STZ working memory (WM), reference memory (RM), as well passive avoidance (PA) behavior decreased, deteriorating progressively during the investigation period. The latter were accompanied by a permanent deficit in cerebral energy metabolism. The ongoing deterioration in behavior and the sustained deficit in cerebral energy metabolism occurring after a triplicate i.c.v. STZ administration lead us to assume that this animal model may be appropriate for the investigation of mechanisms characteristic for sporadic Alzheimer disease. In this context, the effect of Estradiol-17beta (E2) on behavior and energy metabolism was studied. We found that E2 slowed down the i.c.v. STZ-induced deterioration in memory functions, partially compensated the learning deficit, and improved the disturbances in cerebral energy metabolism to the extent that it was almost completely normal again. These findings underscore the beneficial effect of E2 in dementia disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869335     DOI: 10.1007/s007020050111

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  9 in total

Review 1.  Functional aspects of estrogen neuroprotection.

Authors:  Veronica Bisagno; Rachel Bowman; Victoria Luine
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

2.  The effects of estrogens on learning in rats with chronic brain cholinergic deficiency in a Morris water test. Identification of the "passive swimming" component.

Authors:  T V Mukhina; N N Lermontova; G I Van'kin; M Oettel; V K P'chev; S O Bachurin
Journal:  Neurosci Behav Physiol       Date:  2004-03

3.  Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment.

Authors:  Flavia E Saravia; Juan Beauquis; Yanina Revsin; Francoise Homo-Delarche; E Ronald de Kloet; Alejandro F De Nicola
Journal:  Cell Mol Neurobiol       Date:  2006-06-29       Impact factor: 5.046

Review 4.  Evaluating the Role of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease.

Authors:  Jelena Osmanovic-Barilar; Melita Salkovic-Petrisi
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

5.  LX2343 alleviates cognitive impairments in AD model rats by inhibiting oxidative stress-induced neuronal apoptosis and tauopathy.

Authors:  Xiao-Dan Guo; Guang-Long Sun; Ting-Ting Zhou; Yi-Yang Wang; Xin Xu; Xiao-Fan Shi; Zhi-Yuan Zhu; Vatcharin Rukachaisirikul; Li-Hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2017-06-26       Impact factor: 6.150

6.  Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.

Authors:  Katherine Garcia Ravelli; Barbara Dos Anjos Rosário; Rosana Camarini; Marina Sorrentino Hernandes; Luiz Roberto Britto
Journal:  Neurotox Res       Date:  2016-12-02       Impact factor: 3.911

Review 7.  What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research.

Authors:  Melita Salkovic-Petrisic; Ana Knezovic; Siegfried Hoyer; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2012-08-12       Impact factor: 3.575

Review 8.  Effects of high-fructose diets on central appetite signaling and cognitive function.

Authors:  Katrien Lowette; Lina Roosen; Jan Tack; Pieter Vanden Berghe
Journal:  Front Nutr       Date:  2015-03-04

9.  Neuroprotective effects of novel compound Tozan on cognition, neurogenesis and apoptosis in diabetes.

Authors:  Su-Su Tang; Shu-Yun Xing; Xue-Jiao Zhang; Xiao-Qian Ren; Hao Hong; Yan Long
Journal:  Ann Transl Med       Date:  2021-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.